Reducing Flii expression in SCC tumors in-vivo using intradermal injections of FnAb resulted in significantly decreased Flii levels in both the tumor microenvironment and in the serum and led to significantly smaller tumors, both macroscopically and microscopically suggesting that reducing Flii may aid in delaying tumor formation and/or progression. The gene discussed is FLII; the disease is neoplasm.